From: The unfolded protein response is activated in the olfactory system in Alzheimer’s disease
Case | Pathology Diagnosis | Age | Sex | PMD | Braak Stage | Β-amyloid Thal Phase | NIA-AA Score (AD severity) |
---|---|---|---|---|---|---|---|
AZ71 | AD | 68 | F | 6 | VI | 5 | A3 B3 C2 (high) |
AZ75 | AD | 94 | F | 3.5 | V | 5 | A3 B3 C2 (high) |
AZ83 | AD/LBD (neocortical/diffuse) | 60 | F | 16 | VI | 5 | A3 B3 C2 (high) |
AZ84 | AD/LBD (neocortical) | 82 | M | 18.5 | III | 5 | A3 B2 C1 (intermediate) |
AZ86 | AD/LBD (neocortical/diffuse) | 92 | M | 8.5 | III | 5 | A3 B2 C2 (intermediate) |
AZ90 | AD/LBD (amygdala) | 73 | M | 4 | V | 5 | A3 B3 C2 (high) |
AZ95 | AD/LBD (amygdala) | 69 | M | 12 | V | 5 | A3 B3 C2 (high) |
AZ96 | AD/LBD (amygdala) | 74 | F | 8.5 | V | 5 | A3 B3 C2 (high) |
AZ99 | AD | 94 | F | 8.5 | V-VI | 5 | A3 B3 C2 (high) |
AZ101 | AD | 75 | M | 12.5 | VI | 4 | A3 B3 C2 (high) |
AZ103 | AD | 87 | M | 24 | IV | 4 | A3 B2 C2 (intermediate) |
AZ104 | AD/LBD (neocortical/diffuse) | 79 | F | 13 | IV | 5 | A3 B2 C2 (intermediate) |
AZ109 | AD | 90 | F | 31 | III | 4 | A3 B2 C1 (intermediate) |
AZ113 | AD | 77 | M | 3.5 | VI | 5 | A3 B3 C2 (high) |
AZ120 | AD/LBD (amygdala) | 74 | F | 6.5 | IV | 5 | A3 B2 C2 (intermediate) |
H251 | AD | 77 | M | 11.5 | III | 5 | A3 B2 C3 (intermediate) |
OFB55a | NORMAL | 56 | M | 26 | – | – | – |
OFB57a | NORMAL | 63 | M | 36 | – | – | – |
OFB59a | NORMAL | 67 | F | 20 | – | – | – |
OFB6Aa | NORMAL | 82 | M | 24 | – | – | – |
OFB8Aa | NORMAL | 87 | M | 48 | – | – | – |
H190 | NORMAL | 72 | F | 19 | 0 | – | – |
H230 | NORMAL | 57 | F | 32 | 0 | – | – |
H240 | NORMAL | 73 | F | 26.5 | I-II | – | – |
H242 | NORMAL | 61 | M | 19.5 | 0 | – | – |
H243 | NORMAL | 77 | M | 13 | 0 | – | – |
H246 | NORMAL | 89 | F | 17 | I-II | – | – |
H250 | NORMAL | 94 | M | 19 | I-II | – | – |